Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

NEW YORK, January 9, 2026, 20:00 EST — Market closed.

Shares of The Goldman Sachs Group Inc (GS) closed Friday up roughly 0.4%, finishing at $938.98, gaining $4.15 from Thursday’s close. The stock fluctuated between $932.84 and $946.14 during the session, with around 1.1 million shares changing hands.

Goldman now faces a hectic period as major U.S. banks prepare to kick off fourth-quarter earnings. Investors will be watching closely for early signals on the economy and deal activity. “The banks are going to be telling you something that is going to be pretty important because they’re on the front lines,” said Jack Janasiewicz, portfolio manager at Natixis Investment Managers Solutions.

Tuesday delivers December’s consumer price index, a crucial inflation gauge that could shift forecasts for Federal Reserve rate cuts. The Fed is set to meet next on Jan. 27-28. 1

U.S. stocks wrapped up the week strong, with the S&P 500 hitting a new peak at 6,966.28, up 0.65%. December’s jobs report revealed hiring slowed more than anticipated, even as unemployment slipped to 4.4%. One strategist noted investors are “getting granular” in their stock selections.

In deal news, Bloomberg reports CK Hutchison has tapped Goldman and UBS to lead a planned IPO for A.S. Watson, aiming to raise $2 billion or more. The listing is expected to be dual, covering both Hong Kong and London. This move adds another item for investors tracking whether equity issuance is truly picking up. 2

Goldman closes the week roughly 2.4% shy of its 52-week peak at $961.69, while the 52-week trough stands at $439.38. Analysts note resistance near $945.85 and support around $932.41—essentially zones where selling or buying pressure tends to kick in.

Goldman plans to release its fourth-quarter earnings around 7:30 a.m. ET on Jan. 15, with a conference call set for 9:30 a.m. Traders will focus on market trading results, any rise in investment-banking fees, and cost trends as the firm heads into 2026.

But the path ahead is far from certain. A stronger inflation report or new tariff concerns could shake up rate forecasts and weaken demand for bank shares, despite any renewed buzz about deals. 3

Up next: the December 2025 CPI data, due out at 8:30 a.m. ET on Jan. 13. JPMorgan is set to release earnings before the open that day, with Bank of America following on Jan. 14. Morgan Stanley and Goldman Sachs will report on Jan. 15. 4

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape
Previous Story

Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus
Next Story

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Go toTop